Collegium Pharmaceutical Inc (COLL)
29.96
-0.45
(-1.48%)
USD |
NASDAQ |
Nov 22, 16:00
29.92
-0.04
(-0.13%)
Pre-Market: 20:00
Collegium Pharmaceutical Revenue (Annual): 566.77M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 566.77M |
| December 31, 2022 | 463.93M |
| December 31, 2021 | 276.87M |
| December 31, 2020 | 310.02M |
| Date | Value |
|---|---|
| December 31, 2019 | 296.70M |
| December 31, 2018 | 280.41M |
| December 31, 2017 | 28.48M |
| December 31, 2016 | 1.711M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
276.87M
Minimum
2021
566.77M
Maximum
2023
382.86M
Average
310.02M
Median
2020
Revenue (Annual) Benchmarks
| Amicus Therapeutics Inc | 399.36M |
| Insmed Inc | 305.21M |
| Pulmonx Corp | 68.68M |
| RxSight Inc | 89.08M |
| Context Therapeutics Inc | -- |